AIDS, HIV & STDs Market Research Reports & Industry Analysis
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases. HIV infection eventually results in AIDS (acquired immunodeficiency syndrome). This conversion to AIDS may result after 12 or 13 years after the initial infection. Initial HIV symptoms are similar to those of the flu and include fatigue, fever, weight loss, and swollen lymph nodes in the neck, armpits, or groin. Although there is currently no cure for HIV infection, a combination of medications called Highly Active AntiRetroviral Therapy (HAART), and now referred to as AART, helps prolong life in many people. As noted above, person with HIV infection may live for many years before developing any signs of AIDS.
While HIV/AIDS isn’t found in the headlines as much as during the disease’s discovery, more people in the United States are living with HIV/AIDS than ever before. While the incidence of HIV infection in the United States was approximately 0.25% of the population ten to fifteen years ago, it is now approximately 0.47% -- and the population in general has grown.
For this reason, it is important to understand the trends in HIV/AIDS epidemiology and the potential impacts on economies and societies as a whole. These trends emphasize the strategic need for preventive approaches, clinical testing technologies and products, and new therapeutics. Many market research reports provide such information.
AIDS, HIV & STDs Industry Research & Market Reports
-
Cancer Cachexia Market Report by Therapeutics (Progestogens, Corticosteroids, Combination Therapy, and Others), Mode of Action (Appetite Stimulators, Weight Loss Stabilizers), Distribution Channel (Hospital Stores, Retail Pharmacy, Online Pharmacy), and Region 2025-2033
... The market is driven by the rising global cancer incidence, the growing recognition of cachexia's significant impact on patient outcomes, and increased research into targeted therapies, all of which aim to enhance patient quality of ... Read More
-
2025 Global: Hiv Vaccines Market - Innovative Markets Forecast (2031) report
... forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market research ... Read More
-
Herpes Zoster Treatment
... at a CAGR of 1.9% over the analysis period 2024-2030. Antiviral Medications, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$134.0 Million by the end of ... Read More
-
Herpes Simplex Virus Infections
... 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 6.6% CAGR The Herpes Simplex Virus Infections market ... Read More
-
HIV Drugs
... CAGR of 5.2% over the analysis period 2024-2030. Combination HIV Medicines, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$29.0 Billion by the end of the ... Read More
-
Herpes Marker Testing
... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More
-
Kaposi Sarcoma
... CAGR of 3.2% over the analysis period 2024-2030. HAART, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$101.5 Million by the end of the analysis period. ... Read More
-
HIV/AIDS Testing
... CAGR of 6.0% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$3.6 Billion by the end of the analysis period. ... Read More
-
Sexually Transmitted Diseases (STDs) Drug
... Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2024-2030. HPV, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$74.3 Billion by ... Read More
-
Genital Herpes Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Anal Fistula Treatment
... at a CAGR of 4.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$207.5 Million While China is Forecast to Grow at 4.1% CAGR The Anal Fistula Treatment market in the U.S. ... Read More
-
STD Testing
... CAGR of 5.2% over the analysis period 2024-2030. Chlamydia, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of the analysis period. ... Read More
-
Infectious Disease Diagnostics
... at a CAGR of 5.5% over the analysis period 2024-2030. Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion by the end ... Read More
-
Syphilis Immunoassay Diagnostics Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Women's Health Diagnostics Market Report by Type (Diagnostic Devices, Diagnostic Tests), Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Sexually Transmitted Disease Testing, and Others), End User (Hospital and Diagnostics Centers, Home Care), and Region 2025-2033
... 2025-2033. The market is propelled by the rising number of individuals diagnosed with chronic and lifestyle-related diseases, significant technological developments in diagnostic services, increasing awareness about women’s health through numerous campaigns and initiatives by the ... Read More
-
2025 Global Forecast for Hiv Vaccines Market (2026-2031 Outlook)-High Tech Outlook Report
... service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2026 to ... Read More
-
Infectious Disease Molecular Diagnostics Market Size, Share, and Outlook, 2025 Report- By Product & Service (Reagents, Kits, Consumables, Instruments, Software & Services), By Type of Testing (Laboratory Testing, PoC Testing), By Technology (Immunodiagnostics, Polymerase Chain Reaction, Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Others), By Disease Type (Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Chlamydia trachomatis, Neisseria gonorrhea, Tuberculosis, Influenza, Syphilis, Others), By Sample Type (Blood, Serum, and Plasma, Urine, Others), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Others), 2021-2032
... business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Infectious Disease Molecular Diagnostics ... Read More
-
Global HIV Rapid Test Kits Market - Focused Insights 2025-2030
... of rapid test kits acquired one of the leading market players Chembio Diagnostics, which was one of the top market leaders in the global HIV rapid test kits market. In 2022, the WHO partnered with ... Read More
-
Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2025-2029
... the forecast period. The report on the human immunodeficiency virus (HIV) rapid test kits market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around ... Read More
-
Self-Testing Market, by Product Type (Kits (Self-testing kits, Self-collection kits) Self-testing Devices), by Application Type (Blood Glucose Testing, Pregnancy Testing, Pulmonary Function Testing, Urinary Tract Infection Testing, Sexually transmitted infections (STIs) Testing, Genetic Testing, Vitamin and Mineral Deficiency Testing, COVID Testing, Allergy Testing, Gastrointestinal Screening, Hormone Testing, Food Sensitivity Testing, Others (Infectious Disease Testing, etc.)), by Sample Type (Blood, Saliva, Nasal, Stool, Urine and Others (Vaginal Swab Sample and Breathe Sample)), by Test Type (Laboratory Tests, Point of Care Tests/Homecare Tests), by Distribution Channel (Offline (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Supermarkets and Hypermarket) and Online), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America)- Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... it. In order to protect everyone by reducing the likelihood of viral transmission, self-tests can also be used as one of many risk-reduction strategies, such as vaccination, masking, and physical separation. New methods for identifying, ... Read More
-
Sexually Transmitted Infections (STIs) Global Market Report 2025
... infections (stis) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
South East Asia Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (HIV, Influenza, HPV, Oncology, Gene Testing), End User - Forecast to 2031
... The Southeast Asia molecular diagnostics market is projected to reach USD 891.9 million by 2031 from an estimated USD 528.3 million in 2024, at a CAGR of 7.8% during the forecast period. Succeeding extensive secondary ... Read More
-
Womens Health Diagnostics Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
HIV Diagnostics Market by Product (Assay Kits & Reagents, Instrument, Software), Test Type (Rapid Test, ELISA, Western Blot, Viral Load, CD4 Test), End User (Diagnostic Laboratories, Homecare Settings, Hospital) - Global Forecast to 2030
... by several key factors, such as the rising prevalence of HIV/AIDS, the increasing number of blood transfusions and blood donations, advantages offered by POC diagnostic kits & instruments, and the growing focus on initiatives for ... Read More
-
Egypt In-Vitro Diagnostics Market Research Report Information by Product & Service (Reagents & Kits, Instruments, and Software and Services), by Technology (Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, and Others), by Application (Infectious Diseases, Immunology, Oncology, Cardiology, Diabetes, HIV/AIDS, and Others), by End User (Hospitals, Laboratories, Point-of-Care Testing, Research and Academic Institutions, and Others) Industry Forecast to 2032
... urine, tissues, or other body fluids extracted from a patient's body are referred to as in-vitro diagnostics, or IVD. To find illnesses, infections, ailments, or other medical data, these tests are usually carried out in ... Read More
Research Assistance
